Abstract
Cybrid technology was used to replace Leber hereditary optic neuropathy (LHON) causing mitochondrial DNA (mtDNA) mutations from patient-specific fibroblasts with wildtype mtDNA, and mutation-free induced pluripotent stem cells (iPSCs) were generated subsequently. Retinal ganglion cell (RGC) differentiation demonstrates increased cell death in LHON-RGCs and can be rescued in cybrid corrected RGCs.
Original language | English |
---|---|
Pages (from-to) | 1341-1350 |
Number of pages | 10 |
Journal | Aging |
Volume | 9 |
Issue number | 4 |
DOIs | |
Publication status | Published - Apr 2017 |